These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cyclopentenone prostaglandins-new allies in the war on inflammation. Willoughby DA; Moore AR; Colville-Nash PR Nat Med; 2000 Feb; 6(2):137-8. PubMed ID: 10655096 [No Abstract] [Full Text] [Related]
4. Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes. Stevenson MA; Zhao MJ; Asea A; Coleman CN; Calderwood SK J Immunol; 1999 Nov; 163(10):5608-16. PubMed ID: 10553090 [TBL] [Abstract][Full Text] [Related]
5. Aspirin: a neuroprotective agent at high doses? Gomes I Natl Med J India; 1998; 11(1):14-7. PubMed ID: 9557513 [TBL] [Abstract][Full Text] [Related]
8. Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). Anderson DR; Meyers MJ; Vernier WF; Mahoney MW; Kurumbail RG; Caspers N; Poda GI; Schindler JF; Reitz DB; Mourey RJ J Med Chem; 2007 May; 50(11):2647-54. PubMed ID: 17480064 [TBL] [Abstract][Full Text] [Related]
9. MAPKs and their relevance to arthritis and inflammation. Thalhamer T; McGrath MA; Harnett MM Rheumatology (Oxford); 2008 Apr; 47(4):409-14. PubMed ID: 18187523 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation. Zhou HY; Shin EM; Guo LY; Youn UJ; Bae K; Kang SS; Zou LB; Kim YS Eur J Pharmacol; 2008 May; 586(1-3):340-9. PubMed ID: 18378223 [TBL] [Abstract][Full Text] [Related]
11. Therapies for rheumatoid arthritis: hope springs eternal. Smith RJ Drug Discov Today; 2005 Dec; 10(23-24):1598-606. PubMed ID: 16376819 [No Abstract] [Full Text] [Related]
12. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418 [TBL] [Abstract][Full Text] [Related]
13. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology. Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226 [TBL] [Abstract][Full Text] [Related]
14. NSAID toxicity: where are we and how do we go forward? Hawkey CJ J Rheumatol; 2002 Apr; 29(4):650-2. PubMed ID: 11950001 [No Abstract] [Full Text] [Related]